| | | | | | | | | | |
|
|
| Dockets Entered
On January 26, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2000P-1491
|
| Amend Definition & Standard of Identy for Parmesan Cheese
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| 2003P-0132
|
| Part 135 FDA regulations standard of identity frozen dessert
|
|
|
| 2004P-0223
|
| Whole Grain Descriptive Claims
|
|
|
| 2005N-0457
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination
|
|
|
|
|
|
| 2005P-0273
|
| Add Calcium to the Mandatory List
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2005P-0420
|
| Establish therapeutic equivalence requirements for any generic or following-on drug product referencing Adderall XR MASP
|
|
|
| 2006N-0010
|
| Able Laboratories, Inc.; Withdrawal of Approval of 43 Abbreviated New Drug Applications
|
|
|
| 2006P-0049
|
| reduce the public health risks associated with the use of drugs manufactured or processed at foreign facilities
|
|
|
| 2006P-0054
|
| 513(f) Petition for the SCRAM Bracelet (and Collectively, the SCRAM System) as a Class I Medical Device
|
|
|
| 2006V-0053
|
| Laser Light Show
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
17174
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17175
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17176
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17177
|
| Immunotec Research Ltd.
|
| Vol #:
|
| 157
|
|
|
| LET
17178
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17179
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17180
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17181
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17182
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17183
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17184
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17185
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17186
|
| NBTY Inc.
|
| Vol #:
|
| 157
|
|
|
| LET
17187
|
| The Vitamin Shoppe Industries, inc.
|
| Vol #:
|
| 157
|
|
|
| 2000P-1491
|
| Amend Definition & Standard of Identy for Parmesan Cheese
|
|
|
| C
9
|
| European Communities
|
| Vol #:
|
| 1
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
| C 1365
|
| M. Jones
|
| Vol #:
|
| 259
|
|
|
| 2003P-0132
|
| Part 135 FDA regulations standard of identity frozen dessert
|
|
| | | | | | | | |
|
|
| EC
430
|
| Mrs. Susan Damanti
|
| Vol #:
|
| 4
|
|
|
| EC
431
|
| Mrs. Katherine Murray
|
| Vol #:
|
| 4
|
|
|
| EC
432
|
| Mrs. Susan Flynn
|
| Vol #:
|
| 4
|
|
|
| EC
433
|
| Ms. Sandy Griffith
|
| Vol #:
|
| 4
|
|
|
| EC
434
|
| Mrs. Shannon Vestal
|
| Vol #:
|
| 4
|
|
|
| EC
435
|
| Mrs. Wendy Bader
|
| Vol #:
|
| 4
|
|
|
| EC
436
|
| Dr. Wendy Churchill-Urrico
|
| Vol #:
|
| 4
|
|
|
| EC
437
|
| Mrs. Shannon Carducci
|
| Vol #:
|
| 4
|
|
|
| EC
438
|
| Ms. Denise Day
|
| Vol #:
|
| 4
|
|
|
| EC
439
|
| Mrs. Charlene Innerarity
|
| Vol #:
|
| 4
|
|
|
| EC
440
|
| NA
|
| Vol #:
|
| 4
|
|
|
| EC
441
|
| Mrs. Cindy Parker
|
| Vol #:
|
| 4
|
|
|
| EC
442
|
| Mrs. Barbara Miller
|
| Vol #:
|
| 4
|
|
|
| EC
443
|
| Mrs. Nancy Merritt
|
| Vol #:
|
| 4
|
|
|
| EC
444
|
| Ms. Ruth Alvarez
|
| Vol #:
|
| 4
|
|
|
| EC
445
|
| Ms. Julie Bowman
|
| Vol #:
|
| 4
|
|
|
| EC
446
|
| Mrs. Janet Miles-Maestas
|
| Vol #:
|
| 4
|
|
|
| EC
447
|
| Mrs. lisa elmer
|
| Vol #:
|
| 4
|
|
|
| EC
448
|
| Mrs. joanne ohlhausen
|
| Vol #:
|
| 4
|
|
|
| EC
449
|
| Ms. Diane Clagg
|
| Vol #:
|
| 4
|
|
|
| EC
450
|
| Dr. Helene Leonetti
|
| Vol #:
|
| 4
|
|
|
| EC
451
|
| Dr. V Borgmeyer
|
| Vol #:
|
| 4
|
|
|
| EMC 10
|
| M. Beam
|
| Vol #:
|
| 6
|
|
|
| 2005P-0420
|
| Establish therapeutic equivalence requirements for any generic or following-on drug product referencing Adderall XR MASP
|
|
|
| SUP
1
Exhibit
A
|
| Shire Pharmaceuticals Group
|
| Vol #:
|
| 3
|
|
|
| 2006N-0010
|
| Able Laboratories, Inc.; Withdrawal of Approval of 43 Abbreviated New Drug Applications
|
|
|
| LET
1
|
| HFA-305 to Able Laboratories, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2006P-0049
|
| reduce the public health risks associated with the use of drugs manufactured or processed at foreign facilities
|
|
|
| ACK
1
|
| HFA-305 to Litron Laboratories
|
| Vol #:
|
| 1
|
|
|
| 2006P-0054
|
| 513(f) Petition for the SCRAM Bracelet (and Collectively, the SCRAM System) as a Class I Medical Device
|
|
|
| ACK
1
|
| HFA-305 to C. Humphrey & Associates, P.A.
|
| Vol #:
|
| 1
|
|
|
| CCP
1
|
| Alcohol Monitoring Systems
|
| Vol #:
|
| 1
|
|
|
| 2006V-0053
|
| Laser Light Show
|
|
|
| ACK
1
|
| HFA-305 to Fascanition Laser Systems
|
| Vol #:
|
| 1
|
|